Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge
🏛 Centers for Disease Control - NCBDDD
✓ Free, no account · Source: Grants.gov · Last verified Sep 12, 2026
Can you apply?
This grant is for public health organizations and entities with data authority and surveillance infrastructure. State and local health departments, tribal organizations, universities, and public health institutes can apply. Applicants must have capacity to initiate or expand maternal-child surveillance systems and track health outcomes in pregnant women, infants, and children. The funding supports clinical surveillance networks monitoring prenatal exposures and conditions like fetal alcohol spectrum disorders, neonatal abstinence syndrome, and cytomegalovirus.
Organizations can also apply to provide technical assistance and informatics support to surveillance networks. National partnerships focused on FASD prevention, early identification, and family support are eligible. All funded work must align with CDC's public health priorities for maternal-child health.
Not the right fit? Find grants for your organization in 5 questions →
Key dates
- Jul 24, 2026 Applications open
- Apr 26, 2027 Application deadline in 225 days
- Sep 1, 2027 Award announced
- Sep 30, 2027 Project start
Program description
CDC proposes to allocate funds to implement Notice of Funding Opportunity (NOFO) DD-27-0028, Maternal Child Surveillance and Partnerships for Action, Results, and Knowledge. This NOFO will integrate maternal child health surveillance with national partnership activities to address key public health challenges including alcohol use during pregnancy, fetal alcohol spectrum disorders (FASDs), neonatal abstinence syndrome (NAS), and cytomegalovirus (CMV).
The NOFO will support entities with appropriate data authority and infrastructure to initiate, sustain, enhance, and/or expand clinical surveillance systems capturing data on pregnant women, infants, and/or children. Funding will prioritize improving data quality and enabling timely reporting and dissemination of evolving outcome data.
Funded entities participating in clinical surveillance will monitor prenatal exposures such as alcohol use and polysubstance use during pregnancy as well as conditions with significant public health impact such as FASDs, NAS, congenital CMV, and other outcomes. CDC will also fund entities with informatics expertise to provide technical assistance to funded entities conducting clinical surveillance, improve data quality, and support dissemination of data through visualizations. Furthermore, this clinical surveillance network could be leveraged to address emerging, reemerging, and persistent public health threats to pregnant women and infants.
In addition, this NOFO will invest in national partnership activities to prevent FASDs and improve early identification as well as support and care of affected infants and children. Activities may include serving as a national FASD resource; advancing evidence-based messaging; building clinical capacity through a holistic, lifespan approach; addressing regional, state, local, and/or tribal jurisdiction gaps; advancing coordination and translation of activities; and evaluating program strategies.
Together, these activities establish a combined framework that emphasizes data to action approaches that translate high quality surveillance data into prevention strategies, pathways to referral and support, and improved outcomes.
Who can apply
Eligible applicants
- 501(c)(3) Public Charity
- City / Municipal Government
- County Government
- Nonprofits
- Private University
- Public Authority
- Public K-12 School
- Public University
- Small Business (SBA-defined)
- Special District
- State Government
- Tribal Nation
- Tribal Organization
Demographic focus
How to apply
Application links
Key dates & requirements
Required documents
- SF-424 (Application for Federal Assistance)
- Project Narrative describing surveillance system and partnership activities
- Budget and Budget Justification
- Data authority documentation or memoranda of understanding
- Work plan with surveillance metrics and timelines
- Organizational capacity statements
- Letters of commitment from partner organizations
Program contact
- 👤 Amanda Akosa
- 📧 kcq9@cdc.gov
- 📞 404-718-3409
Funding track record
Recent awards under CFDA 93.073 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$102,371,938
-
$38,904,574
-
$7,345,638
-
$6,940,898
-
$6,659,319
-
$5,459,249
-
$5,086,576
-
$4,692,268
-
$4,500,000
-
$4,295,000
Top States by Funding
- DC 4 awards $105.9M
- AL 1 awards $38.9M
- MD 4 awards $19.6M
- NY 5 awards $16.1M
- MA 6 awards $16.1M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.073). How funding has trended year over year.
| 2024 | $59,997,073 | |
| 2025 | $66,807,866 | |
| 2026 est. | $66,807,866 |
FAQ
Who can apply for this grant?
State and local health departments, tribal organizations, universities, and public health agencies with data authority and surveillance infrastructure. Entities providing informatics and technical assistance support also qualify.
What is the deadline?
The fixed deadline is April 26, 2027. Single submission date with no rolling acceptance window.
What activities does this funding support?
Clinical surveillance systems tracking pregnant women and children; monitoring alcohol use, substance use, FASD, NAS, and congenital CMV; technical assistance for data improvement; and national FASD prevention and early identification partnerships.
What makes an application competitive?
Strong existing surveillance infrastructure, clear capacity to improve data quality and timeliness, evidence-based partnership strategies, and alignment with CDC's maternal-child health priorities.
What is the funding range?
Total pool is $51 million. Specific award amounts per applicant were not disclosed. Contact CDC for typical award ranges.
💡 Tips for applicants
- Build your application around existing or planned surveillance infrastructure. Demonstrate that you have the data systems and authority to capture and report timely health outcomes.
- Emphasize data quality and timeliness over volume. CDC prioritizes improving how data is collected, verified, and disseminated to guide action.
- If applying for technical assistance, clearly describe your informatics expertise and how you will support other surveillance partners in the network.
- For FASD prevention partnerships, connect your activities to evidence-based interventions and show coordination with state and local partners.
- Start early. Allow time to confirm data authority agreements, secure institutional partners, and develop realistic timelines for surveillance system expansion.
⚠️ Common mistakes
Applying without established data authority or surveillance infrastructure in place. CDC expects applicants to demonstrate current capacity or concrete plans to build it quickly. Proposing surveillance without a clear plan to translate data into action or policy. Applications that lack evidence of coordination with state and local health departments often fail competitiveness review.
Similar grants
- OPEN Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) — National Institutes of Health
- OPEN US Travelers Health Research, Surveillance, Communication, and Outreach Network — Centers for Disease Control and Prevention - ERA
- CLOSED National HIV Behavioral Surveillance — Centers for Disease Control - NCHHSTP
- OPEN Expanded Surveillance for Pediatric Infectious Diseases — Centers for Disease Control and Prevention - ERA
- OPEN Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) — National Institutes of Health